Gene fusions in cancer: understanding the basics of oncogenic fusion detection strategies
Gene fusions can play a critical role in oncogenesis. The recent progress in next-generation sequencing (NGS) technology has provided significant advances for detection of gene fusions, beyond the resolution level of traditional methods like FISH, IHC and qPCR. In this brief webinar, we will summarize approaches for fusion detection and the important role of fusions for new therapies in cancer.
What will you learn?:
• Learn about different gene fusions present in various cancer types
• Develop an understanding of NGS technology and its advantages for fusion detection
• Gain insight on the important role of fusions for new cancer therapies
Who may this interest?
• Molecular Pathologists & Hematologists
EMEA Technical Lead – Oncology, Staff Clinical Applications Scientist
Illumina (Cambridge, UK)
Agnieszka Grybos-Gajniak is a Clinical Applications Scientist and joined Illumina in 2016. After completing her MSc degree in Biotechnology, she worked for various companies providing solutions for cancer research and diagnostics. Her current position involves specialist support of Illumina’s oncology targeted NGS panels for detection of small variants (SNVs and indels) as well as gene fusions.
In association with: